Page last updated: 2024-11-04

rofecoxib and Cancer of Gastrointestinal Tract

rofecoxib has been researched along with Cancer of Gastrointestinal Tract in 2 studies

Research Excerpts

ExcerptRelevanceReference
" We tested whether long-term use of specific COX-2 inhibitors regress gastric IM."6.72Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. ( Auyeung, AC; Chan, FK; Chan, KF; Chan, WY; Lam, CC; Lau, JY; Leung, WK; Ng, EK; Sung, JJ, 2006)
" We tested whether long-term use of specific COX-2 inhibitors regress gastric IM."2.72Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. ( Auyeung, AC; Chan, FK; Chan, KF; Chan, WY; Lam, CC; Lau, JY; Leung, WK; Ng, EK; Sung, JJ, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaabouni, H1
Amouri, A1
Cheikh, I1
Kchaou, M1
Ouerghi, H1
Ben Mami, N1
Ben Ammar, A1
Leung, WK1
Ng, EK1
Chan, FK1
Chan, WY1
Chan, KF1
Auyeung, AC1
Lam, CC1
Lau, JY1
Sung, JJ1

Reviews

1 review available for rofecoxib and Cancer of Gastrointestinal Tract

ArticleYear
[Selective cyclooxygenase-2 inhibitors and the digestive tract].
    La Tunisie medicale, 2002, Volume: 80, Issue:8

    Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Digestiv

2002

Trials

1 trial available for rofecoxib and Cancer of Gastrointestinal Tract

ArticleYear
Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Aug-01, Volume: 12, Issue:15

    Topics: Adenocarcinoma; Antineoplastic Agents; Double-Blind Method; Drug Administration Schedule; Follow-Up

2006